Replies to post #3021 on NightHawk Biosciences Inc (NHWK)

[xr_biotech_consult]

Phase 2 data to be presented at SITC November 8, 2019 at 7am ET

[Paraceratherium]

Heat presenting at the SITC 34th Annual meeting:

The poster, titled "Treating advanced non-small lung cancer (NSCLC) patients after checkpoint inhibitor treatment failure with a novel combination of Viagenpumatucel-L (HS-110) plus nivolumab," will be presented starting at 7AM Eastern Time on November 8, 2019.